91st General Assembly · Funnel one-pager · Monday, November 9, 2026
SSB 1177: Relating to the controlled substance crystalline polymorph psilocybin
Died when the session ended · The General Assembly adjourned on October 2, 2026. Bills that didn’t pass both chambers died.
What it does
This bill relates to the controlled substance crystalline polymorph psilocybin.201(4)(s)).204(4), a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin shall be immediately removed from schedule I upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act. _____ it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin.
Sponsors
Not listed
Cost
No fiscal note
Senate subcommittee · named February 24, 2025
- Sen. Mike Klimesh (R) · mike.klimesh@legis.iowa.gov
- Sen. David D. Rowley (R) · david.rowley@legis.iowa.gov
- Sen. Zach Wahls (D) · zach.wahls@legis.iowa.gov
Lobbying · 4 for, 0 against
For: Compass Pathways; Dr. Tanja Garrison; Iowa Integrated Health Planning and Advisory Council; Mindspring Mental Health Alliance
In plain words
- February 24, 2025Filed in the Senate and sent to the Health and Human Services committee
- February 24, 2025Senate subcommittee named: Klimesh, Rowley and Wahls
From public records at legis.iowa.gov, compiled by Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/91/SSB1177